Thirdly, we provided a new strategy to reverse the drug resistance induced by TICs, in which ITGB1/NF-κB inhibitors combined with chemotherapy exhibited superior tumor suppressive effects in gastric tumor models. The gene discussed is NFKB1; the disease is gastric neoplasm.